A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer

NCT00496535 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck Neoplasms

Interventions

DRUG: TNFerade biologic

Sponsor

GenVec